KARACHI: The transformative potential of Artificial Intelligence (AI) was highlighted at the tech day titled AIM (Artificial Intelligence for Martin Dow). Organized by Martin Dow Group,the 6th largest pharmaceutical group of Pakistan. This was a first-of-its-kind event where experts from SAP, Salesforce, Microsoft, and PwC shared insights on the role of AI in operational excellence, enhancing customer experience, boosting productivity, and fintech. The forum also featured a CXO panel discussion on embracing AI for business transformation emphasizing the importance of ethical AI and security considerations.
Notable bankers, fintech professionals, and dean and faculty members of academic institutions were also in attendance at the event.
Ali Akhai, Chairman, Martin Dow Group, stated;’ The present and the future belongs to those who are ready to adapt, innovate, and upskill continuously. As individuals and organizations, we will all need to utilize technology for expediting progress with the required sustainability.’
Javed Ghulam Mohammad, Group Managing Director and CEO of Martin Dow, also presented the corporate vision and future direction of the Martin Dow Group.
Speaking at the event, Ijlal Jafri, Group Chief Information Officer, Martin Dow Group, presented the AI strategy and roadmap of the group, ‘At Martin Dow, we see artificial intelligence as a catalyst for meaningful change. With our AI roadmap, we have taken an important step towards building a smarter and more agile future where technology empowers better decisions, stronger outcomes, and drives greater impact across the industry.’
Esteemed speakers and panelists included Saquib Ahmad, Country Managing Director, SAP; Farhan Ibrahim Chaudhry, Head of Sales, Pakistan & RoAsia, Salesforce; Jibran Jamshed, Country Principal Officer, Microsoft; Azfar Ahsan, Chairman Nutshell Group, Saad Kaliya, Partner, A.F. Ferguson and Co; and many others. Talks and discussions focused on business processes, customer engagement, fintech, productivity, and various aspects of AI for business.
Guided by a vision to improve healthcare outcomes and operational excellence, Martin Dow Group remains committed to driving meaningful progress in Pakistan’s pharmaceutical sector by embracing innovation, building strategic partnerships, and integrating future-ready technologies.
